1-[2-(1,3-BENZODIOXOL-5-YL)-ETHYL]-1,1-DIMETHYLHYDRAZINIUM-2,4,6-TRIMETHYLBENZENESULFONATE
Compound with spectra: 1 NMR
![1-[2-(1,3-BENZODIOXOL-5-YL)-ETHYL]-1,1-DIMETHYLHYDRAZINIUM-2,4,6-TRIMETHYLBENZENESULFONATE](/api/compound/cTiWH9AQlw.png?ph=true&h=300&w=458 "1-[2-(1,3-BENZODIOXOL-5-YL)-ETHYL]-1,1-DIMETHYLHYDRAZINIUM-2,4,6-TRIMETHYLBENZENESULFONATE")
| SpectraBase Compound ID | cTiWH9AQlw |
|---|---|
| InChI | InChI=1S/C11H17N2O2.C9H12O3S/c1-13(2,12)6-5-9-3-4-10-11(7-9)15-8-14-10;1-6-4-7(2)9(8(3)5-6)13(10,11)12/h3-4,7H,5-6,8,12H2,1-2H3;4-5H,1-3H3,(H,10,11,12)/q+1;/p-1 |
| InChIKey | CKPWFFCFXJJQAY-UHFFFAOYSA-M |
| Mol Weight | 408.51 g/mol |
| Molecular Formula | C20H28N2O5S |
| Exact Mass | 408.171893 g/mol |
| Parent InChIKey | CXFAZNRUKFTIQW-UHFFFAOYSA-M |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
2-(1,3-benzodioxol-5-yl)-N-(4-ethoxybenzyl)-N-(3-methylbenzyl)ethanaminium
2-(1,3-benzodioxol-5-yl)-N-(4-ethoxybenzyl)-N-(3-methoxybenzyl)ethanaminium
2-(1,3-benzodioxol-5-yl)-N-(4-ethoxybenzyl)-N-(3-fluorobenzyl)ethanaminium
2-(benzo[d][1,3]dioxol-5-yl)-N-(3-bromobenzyl)-N-(4-ethoxybenzyl)ethanamine oxalate
N-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-2,2,3,3,3-pentafluoro-N-propylpropanamide
2-(1,3-benzodioxol-5-yl)-N-[(2,3-dimethoxyphenyl)methyl]ethanamine
N-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-N-ethyl-2,2,3,3,3-pentafluoropropanamide
EPI-JURUENOLIDES-G;(2S,3S,4S)-3-HYDROXY-4-METHYL-2-(15'-PIPERONYL-N-PENTADECYL)-BUTANOLIDE
JURUENOLIDES-G;(2S,3R,4S)-3-HYDROXY-4-METHYL-2-(15'-PIPERONYL-N-PENTADECYL)-BUTANOLIDE
JURUENOLIDES-F;(2S,3R,4S)-3-HYDROXY-4-METHYL-2-(13'-PIPERONYL-N-TRIDECYL)-BUTANOLIDE
| Title | Journal or Book | Year |
|---|---|---|
| Aminimides as Potential CNS-Acting Agents. III. Design, Synthesis, and Receptor Binding of Aminimide Analogues of Dopamine, Serotonin, Morphine, and Nicotine | Australian Journal of Chemistry | 2008 |